eFRIEND for Aging-Related Frailty
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how community health workers can assist frail older adults by offering resources and support through the eFRIEND program. Participants will either receive regular visits and calls from a health worker or continue with their usual care. The goal is to determine if this additional support enhances their daily life. It is suitable for residents of Forsyth County, NC, who are considered frail and have a doctor at Atrium Health Wake Forest Baptist. As an unphased trial, this study provides a unique opportunity to contribute to innovative care strategies for frail older adults.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications, so it's best to ask the trial coordinators for clarification.
What prior data suggests that the eFRIEND program is safe for older adults?
Research shows that the eFRIEND program employs community health workers (CHWs) to support older adults. These workers check in with participants either in person or through video calls. The goal is to help older adults find and use resources they might not know about or have trouble accessing.
Since this program is new and not a medication or medical procedure, specific safety data like that for drugs is unavailable. However, using CHWs in health programs is generally safe. Participants usually feel at ease with them because CHWs are trained to be supportive and understanding. No reports have linked negative effects directly to this type of program.
Overall, the program aims to improve access to resources and care, suggesting a low risk of harm to participants.12345Why are researchers excited about this trial?
Researchers are excited about the eFRIEND program for aging-related frailty because it offers a unique blend of in-person and telehealth care led by Community Health Workers (CHWs). Unlike traditional treatments that might rely heavily on medical interventions or passive monitoring, eFRIEND focuses on regular, personalized contact, which can enhance patient engagement and outcomes. This hybrid approach is designed to be more accessible and flexible for older adults, potentially improving their quality of life and reducing frailty symptoms by providing consistent support and connection.
What evidence suggests that the eFRIEND program is effective for aging-related frailty?
This trial will compare the eFRIEND program, led by community health workers (CHWs), with usual care. Studies have shown that involving CHWs can help older adults manage frailty better. Research indicates that regular check-ins with CHWs, either in person or through video calls, connect people to resources they might not find on their own. These connections are important because they improve access to support and healthcare services. Early findings suggest that this approach may help reduce frailty by addressing both health and social needs. While more evidence is needed to confirm these benefits, the strategy shows promise in supporting older adults.12467
Who Is on the Research Team?
Kathryn E. Callahan, MD
Principal Investigator
Atrium Health Wake Forest Baptist
Are You a Good Fit for This Trial?
This trial is for older adults in Forsyth County, NC who are considered frail (eFI>0.21), connected to an ACO registry, have a PCP within the AHWFB system and have visited their clinic in the past year. It's not for those with dementia or non-English speakers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive regularly scheduled in-person and telehealth contacts with a community health worker (CHW) as part of the eFRIEND program
Follow-up
Participants are monitored for outcomes such as food insecurity, transportation, housing instability, and social isolation
What Are the Treatments Tested in This Trial?
Interventions
- eFRIEND
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor